Clinical Trial

Exercise Impact in Elderly With Multimorbidity: HbA1c and Blood Pressure

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of the study is to compare the effect of two different types of physical exercise modalities on glycated hemoglobin and blood pressure in elderly individuals with multimorbidity. The main characteristic of the proposal is that it is experimental, with two intervention groups with physical exercise that will be randomized in the order of participation of the groups and forwarded to the researchers regarding the evaluations and training periods. In addition, the study will be controlled, as it has a control group that will not perform any intervention with physical exercises during the study period. To allocate the participants in each exercise group and for the control group, the researchers will use the 1:1 method, the user will receive an automatic generator through the random.org website. The main questions raised by the studies will be: Is land-based training more effective than aquatic training for this population in improving the primary outcomes? Is there a difference between training at these intensities and not doing any physical exercise in this population with these primary outcomes? Participants in the 2 intervention groups will: Train 3x per week for 10 weeks at intensities that will progress over the weeks.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-13; most recent amendment 2026-05-25.
Status change: Completed → Active, Not Recruiting 2026-05-25
Trial Details
NCT Number NCT06879639
Lead Sponsor Universidade do Porto
Collaborators: Foundation for Science and Technology, Portugal
Conditions Hypertension, Diabetes, Osteoarthritis, Depression Disorders, Multimorbidity, Respiratory Disorders, Sarcopenia in Elderly, Dyslipidemia +2 more
Enrollment 63 participants
Start Date 2024-09-09
Primary Completion 2024-12-13 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-27